Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Varone

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2025
HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish InsightsSerena Mero, Sara Satolli, Daniele Galatolo, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Eclinicalmedicine|May 17, 2023
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesMarika Pane, Beatrice Berti, Anna Capasso, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
Annals of Clinical and Translational Neurology|March 19, 2026
Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24-Month Follow-Up From the Italian RegistryMarika Pane, Giorgia Coratti, Chiara Cutrì, et al.
Frontiers in Neurology|July 2, 2026
Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophyGiorgia Coratti, Chiara Bravetti, Gianpaolo Cicala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 29, 2022
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADMargherita Nosadini, Michael Eyre, Thea Giacomini, et al.
European Journal of Pediatrics|December 16, 2024
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide surveyAnna Capasso, Gianpaolo Cicala, Martina Ricci, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2025
HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish InsightsSerena Mero, Sara Satolli, Daniele Galatolo, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Eclinicalmedicine|May 17, 2023
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesMarika Pane, Beatrice Berti, Anna Capasso, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
Annals of Clinical and Translational Neurology|March 19, 2026
Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24-Month Follow-Up From the Italian RegistryMarika Pane, Giorgia Coratti, Chiara Cutrì, et al.
Frontiers in Neurology|July 2, 2026
Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophyGiorgia Coratti, Chiara Bravetti, Gianpaolo Cicala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 29, 2022
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADMargherita Nosadini, Michael Eyre, Thea Giacomini, et al.
European Journal of Pediatrics|December 16, 2024
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide surveyAnna Capasso, Gianpaolo Cicala, Martina Ricci, et al.
Pageof 5